Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression

Routine categorization of DLBCL patients into GCB and non-GCB groups by Hans' criteria could not accurately predict chemotherapy resistance and disease progression in patients treated with standard R-CHOP therapy. There is a need to identify better biomarker predictors to enhance assisted selec...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting, Choo-Yuen, Tan, Soo-Yong, Gan, Gin Gin, Zain, Shamsul Mohd, Pung, Yuh-Fen, Ong, Diana Bee-Lan, Bee, Ping Chong
Format: Article
Published: Wiley 2022
Subjects:
Online Access:http://eprints.um.edu.my/41419/
Tags: Add Tag
No Tags, Be the first to tag this record!